CORRELATION OF ULTRASOUND FINDINGS, LIVER AND SPLEEN CYTOLOGY, AND PROGNOSIS IN THE CLINICAL STAGING OF HIGH METASTATIC RISK CANINE MAST CELL TUMORS
- 20 June 2011
- journal article
- Published by Wiley in Veterinary Radiology & Ultrasound
- Vol. 52 (5) , 548-554
Abstract
Cytologic sampling of the ultrasonographically normal spleen and liver is not implemented routinely in the clinical staging of canine cutaneous mast cell tumors and normal ultrasound findings are often accepted as sufficient evidence for ruling out splenic or liver metastasis. Our objective was to define the specificity and sensitivity of ultrasound findings for diagnosis of mast cell infiltration when verified with cytologic evaluation, and to define the prognostic role of cytologic evaluation of liver and splenic aspirates. Dogs with a diagnosis of clinically aggressive grade II, or grade III mast cell tumor treated with a combination vinblastine/CCNU chemotherapy protocol, were selected retrospectively based on availability of cytologic evaluation of spleen plus or minus liver for staging. Out of 19 dogs, 10 dogs had a grade II tumor and nine a grade III tumor. Seven dogs had mast cell infiltration of the spleen, liver, or both. The sensitivity of ultrasound for detecting mast cell infiltration was 43% for the spleen and 0% for the liver. Dogs with positive cytologic evidence of mast cell infiltration to spleen, liver, or both had significantly shorter survival (100 vs. 291 days) than dogs without evidence of mast cell infiltration (P<0.0001). Routine splenic aspiration should be performed regardless of ultrasonographic appearance in dogs with a clinically aggressive mast cell tumor.Keywords
This publication has 29 references indexed in Scilit:
- Efficacy of Vinblastine for Treatment of Canine Mast Cell TumorsJournal of Veterinary Internal Medicine, 2008
- Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisoneBMC Veterinary Research, 2008
- Clinicopathological Features and Outcome for Dogs with Mast Cell Tumors and Bone Marrow InvolvementJournal of Veterinary Internal Medicine, 2008
- Dose‐escalating vinblastine for the treatment of canine mast cell tumourVeterinary and Comparative Oncology, 2008
- Advances in the diagnosis and management of cutaneous mast cell tumours in dogsJournal of Small Animal Practice, 2007
- Cytological comparison of fine‐needle aspirates of liver and spleen of normal dogs and of dogs with cutaneous mast cell tumours and an ultrasonographically normal appearing liver and spleenVeterinary and Comparative Oncology, 2006
- A Multistep Approach in the Cytologic Evaluation of Liver Biopsy Samples of Dogs with Hepatic DiseasesVeterinary Pathology, 2004
- Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgeryAustralian Veterinary Journal, 2003
- Biologic Behavior and Prognostic Factors for Mast Cell Tumors of the Canine Muzzle: 24 Cases (1990–2001)Journal of Veterinary Internal Medicine, 2003
- Relationship of Disease Progression and Plasma Histamine Concentrations in 11 Dogs with Mast Cell TumorsJournal of Veterinary Internal Medicine, 2003